Header Logo

Connection

NANCY DUGAL PERRIER to Adult

Back to Details
This is a "connection" page, showing publications NANCY DUGAL PERRIER has written about Adult.
NANCY DUGAL PERRIER
Connection Strength
1.328
Adult
  1. Beyond the three P's: adrenal involvement in MEN1. Endocr Relat Cancer. 2024 Feb 01; 31(2).
    View in: PubMed
    Score: 0.038
  2. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma? Surgery. 2024 01; 175(1):193-198.
    View in: PubMed
    Score: 0.037
  3. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels. World J Surg. 2023 02; 47(2):363-370.
    View in: PubMed
    Score: 0.035
  4. It's not a mystery, it's in the history: Multidisciplinary management of multiple endocrine neoplasia type 1. CA Cancer J Clin. 2021 09; 71(5):369-380.
    View in: PubMed
    Score: 0.031
  5. Understanding the clinical course of genotype-negative MEN1 patients can inform management strategies. Surgery. 2021 01; 169(1):175-184.
    View in: PubMed
    Score: 0.030
  6. Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Manual for Adrenocortical Carcinoma. World J Surg. 2020 02; 44(2):544-551.
    View in: PubMed
    Score: 0.029
  7. Understanding Thyroidectomy Cost Variations Among National Cancer Institute-Designated Cancer Centers. World J Surg. 2020 02; 44(2):385-392.
    View in: PubMed
    Score: 0.029
  8. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol. 2020 Aug; 61(8):1080-1086.
    View in: PubMed
    Score: 0.028
  9. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol. 2019 Oct; 26(11):3593-3599.
    View in: PubMed
    Score: 0.027
  10. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 2018 11; 164(5):960-964.
    View in: PubMed
    Score: 0.026
  11. Considering Postoperative Functional Hypoaldosteronism after Unilateral Adrenalectomy. Am Surg. 2017 Jun 01; 83(6):598-604.
    View in: PubMed
    Score: 0.024
  12. Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1? Clin Endocrinol (Oxf). 2017 Jun; 86(6):791-797.
    View in: PubMed
    Score: 0.024
  13. Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism. Surgery. 2017 01; 161(1):107-115.
    View in: PubMed
    Score: 0.023
  14. Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol. 2016 Nov; 114(6):708-713.
    View in: PubMed
    Score: 0.023
  15. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients. Clin Endocrinol (Oxf). 2016 09; 85(3):400-7.
    View in: PubMed
    Score: 0.022
  16. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer. 2016 08; 7(4):279-87.
    View in: PubMed
    Score: 0.022
  17. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016 Jul; 31:10-6.
    View in: PubMed
    Score: 0.022
  18. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol. 2016 09; 23(9):2889-97.
    View in: PubMed
    Score: 0.022
  19. Cervical hematoma following an endocrine surgical procedure: The MD Anderson experience. Surgery. 2016 08; 160(2):377-83.
    View in: PubMed
    Score: 0.022
  20. Streamlining variability in hospital charges for standard thyroidectomy: Developing a strategy to decrease waste. Surgery. 2014 Dec; 156(6):1441-9; discussion 1449.
    View in: PubMed
    Score: 0.020
  21. Adrenal metastectomy is safe in selected patients. World J Surg. 2014 Jun; 38(6):1336-42.
    View in: PubMed
    Score: 0.019
  22. Impact of surgical resection for subdiaphragmatic paragangliomas. World J Surg. 2014 Mar; 38(3):733-41.
    View in: PubMed
    Score: 0.019
  23. The role of thyroidectomy in metastatic disease to the thyroid gland. Ann Surg Oncol. 2014 Feb; 21(2):434-9.
    View in: PubMed
    Score: 0.018
  24. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9.
    View in: PubMed
    Score: 0.018
  25. Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better. Am Surg. 2013 Jan; 79(1):84-9.
    View in: PubMed
    Score: 0.018
  26. Predictable criteria for selective, rather than routine, calcium supplementation following thyroidectomy. Arch Surg. 2012 Apr; 147(4):338-44.
    View in: PubMed
    Score: 0.016
  27. Robot-assisted transaxillary thyroid surgery in the United States: is it comparable to open thyroid lobectomy? Ann Surg Oncol. 2012 Apr; 19(4):1269-74.
    View in: PubMed
    Score: 0.016
  28. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011 Sep; 150(3):452-8.
    View in: PubMed
    Score: 0.016
  29. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? Surgery. 2010 Dec; 148(6):1302-9; discussion 1309-10.
    View in: PubMed
    Score: 0.015
  30. Common locations of parathyroid adenomas. Ann Surg Oncol. 2011 Apr; 18(4):1047-51.
    View in: PubMed
    Score: 0.015
  31. Reoperative parathyroidectomy: location of missed glands based on a contemporary nomenclature system. Arch Surg. 2010 Nov; 145(11):1065-8.
    View in: PubMed
    Score: 0.015
  32. Robot assisted transaxillary surgery (RATS) for the removal of thyroid and parathyroid glands. Surgery. 2011 Apr; 149(4):549-55.
    View in: PubMed
    Score: 0.015
  33. Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol. 2009 Nov; 16(11):3146-53.
    View in: PubMed
    Score: 0.014
  34. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg. 2009 Jun; 208(6):1071-6.
    View in: PubMed
    Score: 0.014
  35. Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A. J Surg Educ. 2008 May-Jun; 65(3):182-5.
    View in: PubMed
    Score: 0.013
  36. Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography. J Am Coll Surg. 2008 May; 206(5):888-95; discussion 895-6.
    View in: PubMed
    Score: 0.013
  37. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007 Jul-Aug; 13(4):338-44.
    View in: PubMed
    Score: 0.012
  38. Minimally invasive parathyroidectomy complicated by pneumothoraces: a report of 4 cases. J Surg Educ. 2007 Mar-Apr; 64(2):101-7; discussion 113.
    View in: PubMed
    Score: 0.012
  39. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery. 2006 Dec; 140(6):932-40; discussion 940-1.
    View in: PubMed
    Score: 0.011
  40. Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg. 2006 May; 30(5):686-96.
    View in: PubMed
    Score: 0.011
  41. Abdominal visceral lesions in von Hippel-Lindau disease: incidence and clinical behavior of pancreatic and adrenal lesions at a single center. World J Surg. 2006 May; 30(5):665-9.
    View in: PubMed
    Score: 0.011
  42. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1. World J Surg. 2006 May; 30(5):643-53.
    View in: PubMed
    Score: 0.011
  43. Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery. 2006 Apr; 139(4):527-34.
    View in: PubMed
    Score: 0.011
  44. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg. 2005 Nov; 242(5):642-50.
    View in: PubMed
    Score: 0.011
  45. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005 Mar; 12(3):260-6.
    View in: PubMed
    Score: 0.010
  46. Differential expression of glucose transporters in normal and pathologic thyroid tissue. Thyroid. 2004 Oct; 14(10):806-12.
    View in: PubMed
    Score: 0.010
  47. Is there a racial difference in presentation of primary hyperparathyroidism? Am Surg. 2004 Jun; 70(6):504-6.
    View in: PubMed
    Score: 0.010
  48. Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement. Nat Rev Endocrinol. 2024 Mar; 20(3):168-184.
    View in: PubMed
    Score: 0.009
  49. HER2 expression in thyroid tumors. Am Surg. 2003 Dec; 69(12):1100-3.
    View in: PubMed
    Score: 0.009
  50. Experienced scintigraphers contribute to success of minimally invasive parathyroidectomy by skilled endocrine surgeons. Am Surg. 2003 Jun; 69(6):478-83; discussion 483-4.
    View in: PubMed
    Score: 0.009
  51. Effect of massage technique on sentinel lymph node mapping for cancer of the breast. Am Surg. 2003 Jun; 69(6):520-2.
    View in: PubMed
    Score: 0.009
  52. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism. World J Surg. 2002 Aug; 26(8):907-13.
    View in: PubMed
    Score: 0.008
  53. Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol. 2022 Sep; 29(9):5555-5563.
    View in: PubMed
    Score: 0.008
  54. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab. 2002 Mar; 87(3):1024-9.
    View in: PubMed
    Score: 0.008
  55. A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression. J Clin Endocrinol Metab. 2021 11 19; 106(12):e4969-e4980.
    View in: PubMed
    Score: 0.008
  56. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives. Endocr Relat Cancer. 2020 08; 27(8):T9-T25.
    View in: PubMed
    Score: 0.007
  57. Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020 03; 271(3):399-410.
    View in: PubMed
    Score: 0.007
  58. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020 03; 271(3):e21-e93.
    View in: PubMed
    Score: 0.007
  59. Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP). Am J Surg. 2020 10; 220(4):813-820.
    View in: PubMed
    Score: 0.007
  60. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol. 2019 Dec; 30(4):285-296.
    View in: PubMed
    Score: 0.007
  61. Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in?sporadic medullary thyroid carcinoma. Surgery. 2020 01; 167(1):80-86.
    View in: PubMed
    Score: 0.007
  62. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253.
    View in: PubMed
    Score: 0.007
  63. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. 2019 Aug; 145(8):1977-1986.
    View in: PubMed
    Score: 0.007
  64. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism. JAMA Surg. 2019 04 01; 154(4):e185842.
    View in: PubMed
    Score: 0.007
  65. Bilateral Neck Exploration for Sporadic Primary Hyperparathyroidism: Use Patterns in 5,597 Patients Undergoing Parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. J Am Coll Surg. 2019 04; 228(4):652-659.
    View in: PubMed
    Score: 0.007
  66. Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT. AJNR Am J Neuroradiol. 2019 01; 40(1):142-149.
    View in: PubMed
    Score: 0.007
  67. High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy. Surgery. 2019 01; 165(1):124-128.
    View in: PubMed
    Score: 0.007
  68. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery. 2019 01; 165(1):58-63.
    View in: PubMed
    Score: 0.007
  69. Operation duration and adrenal gland size, but not BMI, are correlated with complication rate for posterior retroperitoneoscopic adrenalectomy for benign diseases. Surgery. 2019 03; 165(3):637-643.
    View in: PubMed
    Score: 0.007
  70. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid. 2018 10; 28(10):1301-1310.
    View in: PubMed
    Score: 0.007
  71. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
    View in: PubMed
    Score: 0.007
  72. Tumor Size and Presence of Metastatic Disease at Diagnosis are Associated with Disease-Specific Survival in Parathyroid Carcinoma. Ann Surg Oncol. 2018 Sep; 25(9):2535-2540.
    View in: PubMed
    Score: 0.006
  73. Thyroid cancer in patients with familial adenomatous polyposis. World J Surg. 1998 Jul; 22(7):738-42; discussion 743.
    View in: PubMed
    Score: 0.006
  74. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg. 2018 07; 268(1):172-178.
    View in: PubMed
    Score: 0.006
  75. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol. 2018 08; 211(2):W109-W115.
    View in: PubMed
    Score: 0.006
  76. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402.
    View in: PubMed
    Score: 0.006
  77. Protein Expression of PTTG1 as a Diagnostic Biomarker in Adrenocortical Carcinoma. Ann Surg Oncol. 2018 Mar; 25(3):801-807.
    View in: PubMed
    Score: 0.006
  78. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution. Surgery. 2018 01; 163(1):212-217.
    View in: PubMed
    Score: 0.006
  79. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness. J Clin Endocrinol Metab. 2017 08 01; 102(8):2807-2813.
    View in: PubMed
    Score: 0.006
  80. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):e463-e470.
    View in: PubMed
    Score: 0.006
  81. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Fam Cancer. 2017 04; 16(2):283-289.
    View in: PubMed
    Score: 0.006
  82. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY). 2017 02; 42(2):577-584.
    View in: PubMed
    Score: 0.006
  83. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid. 2016 11; 26(11):1553-1562.
    View in: PubMed
    Score: 0.006
  84. Effect of adjunctive dexmedetomidine on postoperative intravenous opioid administration in patients undergoing thyroidectomy in an ambulatory setting. J Clin Anesth. 2016 Dec; 35:361-364.
    View in: PubMed
    Score: 0.006
  85. Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery. 2005 Dec; 138(6):1121-8; discussion 1128-9.
    View in: PubMed
    Score: 0.005
  86. An immunohistochemical survey for neuroendocrine cells in regional pancreatic lymph nodes: a plausible explanation for primary nodal gastrinomas? Mayo Clinic Pancreatic Surgery Group. Surgery. 1995 Dec; 118(6):957-65; discussion 965-6.
    View in: PubMed
    Score: 0.005
  87. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol. 2015 Nov; 22(12):3990-5.
    View in: PubMed
    Score: 0.005
  88. Preliminary whole-exome sequencing reveals mutations that imply common tumorigenicity pathways in multiple endocrine neoplasia type 1 patients. Surgery. 2014 Dec; 156(6):1351-7; discussion 1357-8.
    View in: PubMed
    Score: 0.005
  89. Surgical resection of synchronously metastatic adrenocortical cancer. Ann Surg Oncol. 2015 Jan; 22(1):146-51.
    View in: PubMed
    Score: 0.005
  90. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid. 2014 Jul; 24(7):1096-106.
    View in: PubMed
    Score: 0.005
  91. Comparison of attitudes regarding preimplantation genetic diagnosis among patients with hereditary cancer syndromes. Fam Cancer. 2014 Jun; 13(2):291-9.
    View in: PubMed
    Score: 0.005
  92. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg. 2014 Jun; 38(6):1318-27.
    View in: PubMed
    Score: 0.005
  93. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing?s syndrome. Surgery. 2013 Dec; 154(6):1174-83; discussion 1183-4.
    View in: PubMed
    Score: 0.005
  94. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc. 2013 Nov; 27(11):4026-32.
    View in: PubMed
    Score: 0.005
  95. The biopsy-proven benign thyroid nodule: is long-term follow-up necessary? J Am Coll Surg. 2013 Jul; 217(1):81-8; discussion 88-9.
    View in: PubMed
    Score: 0.004
  96. Telementoring: a multi-institutional experience with the introduction of a novel surgical approach for adrenalectomy. Ann Surg Oncol. 2013 Aug; 20(8):2754-8.
    View in: PubMed
    Score: 0.004
  97. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan; 98(1):192-7.
    View in: PubMed
    Score: 0.004
  98. Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism. Radiology. 2012 Sep; 264(3):789-95.
    View in: PubMed
    Score: 0.004
  99. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. 2012 Jun; 151(6):851-9.
    View in: PubMed
    Score: 0.004
  100. Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. Surgery. 2011 Dec; 150(6):1143-52.
    View in: PubMed
    Score: 0.004
  101. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12.
    View in: PubMed
    Score: 0.004
  102. Imaging characteristics of hyperfunctioning parathyroid adenomas using multiphase multidectector computed tomography: a quantitative and qualitative approach. J Comput Assist Tomogr. 2011 Sep-Oct; 35(5):560-7.
    View in: PubMed
    Score: 0.004
  103. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clin Radiol. 2012 Jan; 67(1):38-46.
    View in: PubMed
    Score: 0.004
  104. Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. Hum Pathol. 2011 Sep; 42(9):1213-20.
    View in: PubMed
    Score: 0.004
  105. Cystic lymph nodes in the lateral neck as indicators of metastatic papillary thyroid cancer. Endocr Pract. 2011 Mar-Apr; 17(2):240-4.
    View in: PubMed
    Score: 0.004
  106. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25.
    View in: PubMed
    Score: 0.004
  107. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome. Nat Rev Endocrinol. 2010 Feb; 6(2):110-5.
    View in: PubMed
    Score: 0.004
  108. Routine pre-operative ultrasonography for papillary thyroid cancer: effects on cervical recurrence. Surgery. 2009 Dec; 146(6):1063-72.
    View in: PubMed
    Score: 0.004
  109. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane. Ann Surg Oncol. 2010 Jan; 17(1):263-70.
    View in: PubMed
    Score: 0.004
  110. Cognitive and affective sequelae of primary hyperparathyroidism and early response to parathyroidectomy. J Int Neuropsychol Soc. 2009 Nov; 15(6):1002-11.
    View in: PubMed
    Score: 0.004
  111. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
    View in: PubMed
    Score: 0.003
  112. Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer. Oncol Rep. 2008 May; 19(5):1311-21.
    View in: PubMed
    Score: 0.003
  113. Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer. Mol Carcinog. 2008 Feb; 47(2):88-99.
    View in: PubMed
    Score: 0.003
  114. Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. Surgery. 2007 Dec; 142(6):867-75; discussion 867-75.
    View in: PubMed
    Score: 0.003
  115. Failure to recognize multiple endocrine neoplasia 2B: more common than we think? Ann Surg Oncol. 2008 Jan; 15(1):293-301.
    View in: PubMed
    Score: 0.003
  116. Followup of patients with papillary thyroid cancer: in search of the optimal algorithm. J Am Coll Surg. 2007 Aug; 205(2):239-47.
    View in: PubMed
    Score: 0.003
  117. Primary adrenal natural killer/T-cell nasal type lymphoma: first case report in adults. Am J Hematol. 2007 Apr; 82(4):299-303.
    View in: PubMed
    Score: 0.003
  118. Carcinoid tumors of the duodenum. Surgery. 2005 Dec; 138(6):971-7; discussion 977-8.
    View in: PubMed
    Score: 0.003
  119. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery. 2005 Dec; 138(6):1078-85; discussion 1085-6.
    View in: PubMed
    Score: 0.003
  120. Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg. 2005 Apr; 140(4):374-82.
    View in: PubMed
    Score: 0.003
  121. Detection of an intrathymic parathyroid adenoma using single-photon emission CT 99mTc sestamibi scintigraphy and CT. AJR Am J Roentgenol. 2005 Mar; 184(3 Suppl):S16-8.
    View in: PubMed
    Score: 0.003
  122. Intraoperative imprint cytologic evaluation of sentinel lymph nodes for lobular carcinoma of the breast. Ann Surg. 2004 Jan; 239(1):61-6.
    View in: PubMed
    Score: 0.002
  123. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med. 2003 Dec; 28(12):955-60.
    View in: PubMed
    Score: 0.002
  124. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2003 Nov; 12(11 Pt 1):1200-4.
    View in: PubMed
    Score: 0.002
  125. Biopsy needle technique and the accuracy of diagnosis of atypical ductal hyperplasia for mammographic abnormalities. Am Surg. 2003 Sep; 69(9):757-62; discussion 762.
    View in: PubMed
    Score: 0.002
  126. Differing histologic findings after bilateral and focused parathyroidectomy. J Am Coll Surg. 2003 Apr; 196(4):535-40.
    View in: PubMed
    Score: 0.002
  127. Positron emission mammography: initial clinical results. Ann Surg Oncol. 2003 Jan-Feb; 10(1):86-91.
    View in: PubMed
    Score: 0.002
  128. Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg. 1999 Jul; 134(7):699-704; discussion 704-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.